General situation of Fu Rui Group Co., Ltd.

Inner Mongolia Furuimeng Chinese Medicine Technology Co., Ltd., formerly known as Inner Mongolia Fu Rui Pharmaceutical Co., Ltd., was established on June 26th, 2008+1 1998. On February 26th, 20001,12, in order to better adapt to the competitive environment of market economy and the needs of standardized management of modern enterprises, the company was restructured into a joint stock limited company with an existing registered capital of 55 million yuan. Shareholders include China High-tech Investment Group Company, Shenzhen Erdos Asset Management Co., Ltd. and other enterprises and natural persons.

Inner Mongolia Furuimeng Traditional Chinese Medicine Technology Co., Ltd. adheres to the development strategy of "professionally serving the field of liver diseases with anti-hepatic fibrosis as the core" and is committed to establishing a professional service system with Fu Rui characteristics. Since its establishment, the company has taken it as its responsibility to create value for society. Through the joint efforts of all my colleagues, we have improved the cognitive level of the whole society on liver fibrosis, provided advanced and accurate diagnosis methods and effective drugs for patients with liver diseases, and brought health to patients with liver diseases. On this basis, it reflects the value of the company's existence and development.